63 related articles for article (PubMed ID: 20595016)
21. Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp.
Wang XD; Meng MX; Gao LB; Liu T; Xu Q; Zeng S
Int J Pharm; 2009 Aug; 378(1-2):1-8. PubMed ID: 19465099
[TBL] [Abstract][Full Text] [Related]
22. Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs.
Leung S; Bendayan R
Can J Physiol Pharmacol; 1999 Aug; 77(8):625-30. PubMed ID: 10543726
[TBL] [Abstract][Full Text] [Related]
23. Unique pharmacology of KAR-2, a potential anti-cancer agent: absorption modelling and selective mitotic spindle targeting.
Gonzalez-Alvarez I; Gonzalez-Alvarez M; Oltra-Noguera D; Merino V; Tõkési N; Ovádi J; Bermejo M
Eur J Pharm Sci; 2009 Jan; 36(1):11-9. PubMed ID: 19028571
[TBL] [Abstract][Full Text] [Related]
24. Limited interaction between tacrolimus and P-glycoprotein in the rat small intestine.
Saitoh H; Saikachi Y; Kobayashi M; Yamaguchi M; Oda M; Yuhki Y; Achiwa K; Tadano K; Takahashi Y; Aungst BJ
Eur J Pharm Sci; 2006 May; 28(1-2):34-42. PubMed ID: 16457995
[TBL] [Abstract][Full Text] [Related]
25. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
26. Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice.
Djuv A; Nilsen OG
Phytother Res; 2008 Dec; 22(12):1623-8. PubMed ID: 19003953
[TBL] [Abstract][Full Text] [Related]
27. P-Glycoprotein expression in human retinal pigment epithelium cell lines.
Constable PA; Lawrenson JG; Dolman DE; Arden GB; Abbott NJ
Exp Eye Res; 2006 Jul; 83(1):24-30. PubMed ID: 16530756
[TBL] [Abstract][Full Text] [Related]
28. Everted rat intestinal sacs: a new model for the quantitation of P-glycoprotein mediated-efflux of anticancer agents.
Carreño-Gómez B; Duncan R
Anticancer Res; 2000; 20(5A):3157-61. PubMed ID: 11062737
[TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model.
Schrickx J; Fink-Gremmels J
J Vet Pharmacol Ther; 2007 Feb; 30(1):25-31. PubMed ID: 17217397
[TBL] [Abstract][Full Text] [Related]
30. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles.
Bebawy M; Morris MB; Roufogalis BD
Anal Biochem; 1999 Mar; 268(2):270-7. PubMed ID: 10075817
[TBL] [Abstract][Full Text] [Related]
31. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.
Sugihara N; Toyama K; Michihara A; Akasaki K; Tsuji H; Furuno K
Toxicology; 2006 Jun; 223(1-2):156-65. PubMed ID: 16647797
[TBL] [Abstract][Full Text] [Related]
32. Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function.
Miliotis T; Ali L; Palm JE; Lundqvist AJ; Ahnoff M; Andersson TB; Hilgendorf C
Drug Metab Dispos; 2011 Dec; 39(12):2440-9. PubMed ID: 21949244
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory Effects of Benzaldehyde, Vanillin, Muscone and Borneol on P-Glycoprotein in Caco-2 Cells and Everted Gut Sac.
Wang S; Tan N; Ma C; Wang J; Jia P; Liu J; Yang Y; Xie Z; Zhao K; Zheng X
Pharmacology; 2018; 101(5-6):269-277. PubMed ID: 29502118
[TBL] [Abstract][Full Text] [Related]
34. Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system.
Nakayama A; Saitoh H; Oda M; Takada M; Aungst BJ
Eur J Pharm Sci; 2000 Oct; 11(4):317-24. PubMed ID: 11033075
[TBL] [Abstract][Full Text] [Related]
35. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.
Zhang S; Morris ME
Pharm Res; 2003 Aug; 20(8):1184-91. PubMed ID: 12948016
[TBL] [Abstract][Full Text] [Related]
36. Model analysis of the concentration-dependent permeability of P-gp substrates.
Tachibana T; Kitamura S; Kato M; Mitsui T; Shirasaka Y; Yamashita S; Sugiyama Y
Pharm Res; 2010 Mar; 27(3):442-6. PubMed ID: 20135207
[TBL] [Abstract][Full Text] [Related]
37. Flavonoids alter P-gp expression in intestinal epithelial cells in vitro and in vivo.
Lohner K; Schnäbele K; Daniel H; Oesterle D; Rechkemmer G; Göttlicher M; Wenzel U
Mol Nutr Food Res; 2007 Mar; 51(3):293-300. PubMed ID: 17295420
[TBL] [Abstract][Full Text] [Related]
38. Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.
Ekins S; Kim RB; Leake BF; Dantzig AH; Schuetz EG; Lan LB; Yasuda K; Shepard RL; Winter MA; Schuetz JD; Wikel JH; Wrighton SA
Mol Pharmacol; 2002 May; 61(5):974-81. PubMed ID: 11961114
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of P-glycoprotein expression by ophthalmic drugs in different corneal in-vitro models.
Verstraelen J; Reichl S
J Pharm Pharmacol; 2015 May; 67(5):605-15. PubMed ID: 25643948
[TBL] [Abstract][Full Text] [Related]
40. GP at Hand: Where have the new patients come from?
Iacobucci G
BMJ; 2018 May; 361():k2227. PubMed ID: 29776988
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
